We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

172 hedge funds and large institutions have $670M invested in Anika Therapeutics in 2017 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 65 increasing their positions, 54 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 16

20% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 54

4% more funds holding

Funds holding: 166 → 172 (+6)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.19% less ownership

Funds ownership: 84.91% → 84.72% (-0.19%)

8% less capital invested

Capital invested by funds: $726M → $670M (-$55.9M)

Holders
172
Holders Change
+6
Holders Change %
+3.61%
% of All Funds
3.9%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
65
Reduced
54
Closed
16
Calls
$809K
Puts
–
Net Calls
+$809K
Net Calls Change
-$161K

Top Buyers

1
CWAM
Columbia Wanger Asset Management
Illinois
+$3.37M
2
BlackRock
BlackRock
New York
+$3.22M
3
TAM
THB Asset Management
Connecticut
+$1.42M
4
HSA
Hussman Strategic Advisors
Maryland
+$1.38M
5
Deutsche Bank
Deutsche Bank
Germany
+$1.21M

Top Sellers

1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$6.14M
2
NAP
New Amsterdam Partners
New York
-$3.76M
3
SEI Investments
SEI Investments
Pennsylvania
-$2.26M
4
NFA
Nationwide Fund Advisors
Ohio
-$1.77M
5
KCM
Kennedy Capital Management
Missouri
-$1.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
MSA
126
Mason Street Advisors
Wisconsin
$206K +$5.59K +101 +3%
FGC
127
Financial Gravity Companies
Texas
$200K +$166K +3,003 New
MCM
128
Mainstay Capital Management
Michigan
$180K +$185K +3,342 New
SEI Investments
129
SEI Investments
Pennsylvania
$171K -$2.26M -40,881 -93%
MOS
130
MGO One Seven
Ohio
$160K +$165K +2,973 New
SOADOR
131
State of Alaska Department of Revenue
Alaska
$156K – – –
Federated Hermes
132
Federated Hermes
Pennsylvania
$153K -$125K -2,250 -44%
Bank of Montreal
133
Bank of Montreal
Ontario, Canada
$150K -$906K -16,369 -85%
Parallax Volatility Advisers
134
Parallax Volatility Advisers
California
$118K +$121K +2,184 New
APA
135
American Portfolios Advisors
New York
$116K +$119K +2,150 New
PNC Financial Services Group
136
PNC Financial Services Group
Pennsylvania
$99K – – –
EARNEST Partners
137
EARNEST Partners
Georgia
$81K +$83K +1,500 New
SGAM
138
Smith Group Asset Management
Texas
$80K – – –
GT
139
Glenmede Trust
Pennsylvania
$75K -$13.8K -250 -15%
AIP
140
Ameritas Investment Partners
Nebraska
$62K – – –
US Bancorp
141
US Bancorp
Minnesota
$57K – – –
IWM
142
IHT Wealth Management
Illinois
$57K +$6.09K +110 +12%
AG
143
Advisor Group
Arizona
$52K -$36.5K -659 -40%
Zurich Cantonal Bank
144
Zurich Cantonal Bank
Switzerland
$52K +$21.2K +383 +67%
RFC
145
Regions Financial Corp
Alabama
$39K +$39.8K +719 New
FPB
146
First PREMIER Bank
South Dakota
$38K – – –
Group One Trading
147
Group One Trading
Illinois
$22K -$111K -2,000 -83%
TDC
148
Thompson Davis & Co
Virginia
$22K -$8.3K -150 -27%
MSFP
149
Mark Sheptoff Financial Planning
Connecticut
$16K – – –
SWA
150
Sutton Wealth Advisors
Florida
$14.1K – – –
4 5
6
7 8

ANIK Hedge Fund Activity: Q4 2017 in Review

172 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2017, worth a combined $670M — down 7.7% from $726M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new ANIK positions and 16 closed out — a net gain of 7 holders — while 65 added to existing stakes and 54 trimmed.

The largest buyer was Columbia Wanger Asset Management, adding an estimated $3.37M. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $6.14M sold.

  • 172 institutional investors held Anika Therapeutics (ANIK) as of Q4 2017, up from 166 in Q3 2017.
  • Funds reported $670M of Anika Therapeutics stock for Q4 2017, down 7.7% quarter-over-quarter.
  • 23 funds opened new Anika Therapeutics positions in Q4 2017 and 16 closed out, a net change of +7 holders.
  • The largest Anika Therapeutics buyer in Q4 2017 was Columbia Wanger Asset Management, an estimated $3.37M added.
  • The largest Anika Therapeutics seller in Q4 2017 was Polar Asset Management Partners, an estimated $6.14M sold.

Based on aggregated 13F filings for Q4 2017.